Several States Pausing Use of Johnson & Johnson Vaccine After CDC, FDA Advisory - The N... - 0 views
-
Several states quickly followed the call from federal health agencies on Tuesday to pause the administration of Johnson & Johnson’s vaccine after six women in the United States developed a rare disorder involving blood clots within one to three weeks of vaccination.
-
CVS and Walgreens, the nation’s largest retail pharmacy chains, also said that they would immediately stop Johnson & Johnson vaccinations.
-
The C.D.C.’s outside advisory committee of independent experts has scheduled an emergency meeting for Wednesday.
- ...11 more annotations...
-
The White House on Tuesday said that the pause will not have a significant effect on the country’s vaccination campaign, which has accelerated in recent weeks as a rise in new virus cases threatens a fourth possible surge.
-
“Over the last few weeks, we have made available more than 25 million doses of Pfizer and Moderna each week, and in fact this week we will make available 28 million doses of these vaccines,” Jeff Zients, the White House Covid-19 response coordinator, said on Tuesday.
-
As of Monday, 36 percent of the country’s total population has received at least one shot of a vaccine, and 22 percent are fully vaccinated, according to data from the C.D.C.
-
Even though the reaction to the Johnson & Johnson shot is rare, any questions about the safety of the shots could bolster vaccine hesitancy.
-
Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the C.D.C. The six women who developed blood clots were between the ages of 18 and 48.
-
“I know there are people who have gotten the vaccine, who are probably very concerned. For people who got the vaccine more than a month ago, the risk to them is very low at this time,” Dr. Schuchat said.
-
On Friday, Gov. Andrew M. Cuomo said that New York expected to receive 34,900 Johnson & Johnson shots, a decrease of 88 percent from the previous week
-
Dr. Zucker, New York’s health commissioner, said that the state would honor appointments made at state-run mass vaccination sites for the Johnson & Johnson vaccine by giving people the Pfizer-BioNTech vaccine instead.
-
Mayor Bill de Blasio of New York City said that the city would do the same, rescheduling appointments at city-run vaccine sites.“Every site has been told this morning to stop giving the J&J shots,” he said at a news conference.
-
Both Mr. Cuomo and Mr. de Blasio received the Johnson & Johnson vaccine at separate appearances last month, which they framed as an effort to boost confidence in that vaccine’s efficacy rate and to address vaccine hesitancy.
-
Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers.